New funding

The lab has been awarded funding from the NCI Cancer Systems Biology Consortium. This project aims to use systems-level signaling measurements and modeling to determine which lung cancer tumors will respond to AXL inhibitors. The work is in collaboration with the Haura (Moffitt) and White labs.